MRSA Research - Methicillin-Resistant Staphylococcus Aureus, Hospitals, Infection, Antibiotic Resistance, Superbugs

MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.


MRSA Research Today

Home

View Latest Issue

Information About MRSA

Books on MRSA

Advertising in Research Today

View Other Research Today Publications



Volume 7 (2010), Issue 9 (September)

  1. Comprehensive characterization of methicillin-resistant Staphylococcus aureus subsp. aureus COL secretome by two-dimensional liquid chromatography and mass spectrometry.
    Mol Cell Proteomics, 9(9): 1898-919. [Abstract] [Full-text]
  2. Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers.
    Diabetologia, 53(10): 2249-55. [Abstract] [Full-text]
  3. Why antibodies disobey the Hippocratic Oath and end up doing harm: a new clue.
    J Clin Invest, 120(9): 3099-102. [Abstract] [Full-text]
  4. Breast implant infections: is cefazolin enough?
    Plast Reconstr Surg, 126(3): 779-85. [Abstract] [Full-text]
  5. Evidence of Multiple Virulence Subtypes in Nosocomial and Community-Associated MRSA Genotypes in Companion Animals from the Upper Midwestern and Northeastern United States.
    Clin Med Res. [Abstract] [Full-text]
  6. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results.
    Infect Control Hosp Epidemiol, 31(10): 1043-8. [Abstract] [Full-text]
  7. Staphylococcus aureus: a continuously evolving and formidable pathogen in the neonatal intensive care unit.
    Clin Perinatol, 37(3): 535-46. [Abstract] [Full-text]
  8. Room decontamination with UV radiation.
    Infect Control Hosp Epidemiol, 31(10): 1025-9. [Abstract] [Full-text]
  9. Systemic Loxoscelism in the Age of Community-Acquired Methicillin-Resistant Staphylococcus aureus.
    Ann Emerg Med. [Abstract] [Full-text]
  10. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among health care workers in a cancer center.
    Am J Infect Control. [Abstract] [Full-text]
  11. Reducing surgical site infections by bundling multiple risk reduction strategies and active surveillance.
    AORN J, 92(3): 288-96. [Abstract] [Full-text]
  12. Microstructuring of polymer films for sensitive genotyping by real-time PCR on a centrifugal microfluidic platform.
    Lab Chip, 10(19): 2519-26. [Abstract] [Full-text]
  13. Resistant pathogen-associated skin and skin-structure infections: antibiotic options.
    Expert Rev Anti Infect Ther, 8(9): 1019-36. [Abstract] [Full-text]
  14. Interventions to improve hand hygiene compliance in patient care.
    Cochrane Database Syst Rev, 9: CD005186. [Abstract] [Full-text]
  15. Treatment of infections caused by antimicrobial-resistant gram-positive bacteria.
    Am J Med Sci, 340(3): 209-17. [Abstract] [Full-text]
  16. Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae).
    Comp Biochem Physiol C Toxicol Pharmacol, 152(4): 467-72. [Abstract] [Full-text]
  17. Impact of traditional hospital strain of methicillin-resistant Staphylococcus aureus (MRSA) and community strain of MRSA on mortality in patients with community-onset S aureus bacteremia.
    Medicine (Baltimore), 89(5): 285-94. [Abstract] [Full-text]
  18. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus.
    Annu Rev Microbiol, 64: 143-62. [Abstract] [Full-text]
  19. Radiosynthesis and biodistribution of (99m)Tc-rifampicin: a novel radiotracer for in-vivo infection imaging.
    Appl Radiat Isot, 68(12): 2255-60. [Abstract] [Full-text]
  20. Chemical composition, antimicrobial and antioxidant activities of the essential oils of Sideritis erythrantha Boiss. and Heldr. (var. erythrantha and var. cedretorum P.H. Davis) endemic in Turkey.
    Food Chem Toxicol, 48(10): 2960-5. [Abstract] [Full-text]
  21. Increasing prevalence of nasal and rectal colonization with methicillin-resistant Staphylococcus aureus in children with cancer.
    Pediatr Blood Cancer. [Abstract] [Full-text]
  22. agr-Dependent Interactions of Staphylococcus aureus USA300 with Human Polymorphonuclear Neutrophils.
    J Innate Immun, 2(6): 546-559. [Abstract] [Full-text]
  23. Superantigen gene profiles and presence of exfoliative toxin genes in community-acquired methicillin-resistant Staphylococcus aureus isolated from Chinese children.
    J Med Microbiol. [Abstract] [Full-text]
  24. Radiosynthesis and biodistribution of (99m)Tc-rifampicin: a novel radiotracer for in-vivo infection imaging.
    Appl Radiat Isot, 68(12): 2255-60. [Abstract] [Full-text]
  25. Radiosynthesis and biodistribution of (99m)Tc-rifampicin: a novel radiotracer for in-vivo infection imaging.
    Appl Radiat Isot, 68(12): 2255-60. [Abstract] [Full-text]
  26. Epidemiology of non-multiresistant methicillin-resistant Staphylococcus aureus infection in Queensland, Australia: associations with indigenous populations and Panton-Valentine leukocidin.
    Eur J Clin Microbiol Infect Dis, 29(10): 1253-9. [Abstract] [Full-text]
  27. Absence of bacterial resistance to medical-grade manuka honey.
    Eur J Clin Microbiol Infect Dis, 29(10): 1237-41. [Abstract] [Full-text]
  28. First outbreak of PVL-positive nonmultiresistant MRSA in a neonatal ICU in Australia: comparison of MALDI-TOF and SNP-plus-binary gene typing.
    Eur J Clin Microbiol Infect Dis, 29(10): 1311-4. [Abstract] [Full-text]
  29. Crystal structure of Staphylococcus aureus metallopeptidase (Sapep) reveals large domain motions between the manganese-bound and apo-states.
    J Biol Chem, 285(38): 29406-15. [Abstract] [Full-text]
  30. Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients.
    Eur J Clin Microbiol Infect Dis, 29(10): 1277-85. [Abstract] [Full-text]
  31. Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007.
    Ann Saudi Med, 30(5): 358-63. [Abstract] [Full-text]
  32. Adverse event associated with a change in nonprescription syringe sale policy.
    J Am Pharm Assoc (2003), 50(5): 619-22. [Abstract] [Full-text]
  33. Deep venous thrombosis associated with acute hematogenous osteomyelitis in children.
    Orthop Traumatol Surg Res. [Abstract] [Full-text]
  34. Recurrent skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus requiring operative debridement.
    Am J Surg. [Abstract] [Full-text]
  35. Fulminant fatal swine influenza (H1N1): Myocarditis, myocardial infarction, or severe influenza pneumonia?
    Heart Lung, 39(5): 453-8. [Abstract] [Full-text]
  36. On resin amino acid side chain attachment strategy for the head to tail synthesis of new glutamine containing gramicidin-S analogs and their antimicrobial activity.
    Bioorg Med Chem Lett, 20(19): 5701-4. [Abstract] [Full-text]
  37. Screening of the constituents, antimicrobial and antioxidant activity of endemic Origanum hypericifolium O. Schwartz & P.H. Davis.
    Nat Prod Res, 24(16): 1568-77. [Abstract] [Full-text]
  38. Original article. Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis.
    J Clin Pharm Ther, 35(5): 527-32. [Abstract] [Full-text]
  39. Natural product derivatives with bactericidal activity against Gram-positive pathogens including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Bioorg Med Chem Lett, 20(19): 5936-8. [Abstract] [Full-text]
  40. Forearm pyomyositis in a breast cancer patient on chemotherapy.
    J Plast Reconstr Aesthet Surg, 63(10): e737-9. [Abstract] [Full-text]
  41. Patterns of early and late ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus in a trauma population.
    J Trauma, 69(3): 519-22. [Abstract] [Full-text]
  42. Daptomycin and rifampin for the treatment of methicillin-resistant Staphylococcus aureus septic pulmonary emboli in the absence of endocarditis.
    Microb Drug Resist, 16(3): 241-4. [Abstract] [Full-text]
  43. Two New Xanthones from Hypericum sampsonii and biological activity of the isolated compounds.
    Phytother Res. [Abstract] [Full-text]
  44. Molecular characteristics of methicillin-resistant Staphylococcus aureus blood isolates: clonal spread of staphylococcal cassette chromosome mec type IVA between the community and the hospital.
    Microb Drug Resist, 16(3): 217-22. [Abstract] [Full-text]
  45. Tracing the source of an outbreak of methicillin-resistant Staphylococcus aureus in a tertiary-care oncology hospital by epidemiology and molecular methods.
    Microb Drug Resist, 16(3): 203-8. [Abstract] [Full-text]
  46. Binding of the gene repressor BlaI to the bla operon in methicillin-resistant Staphylococcus aureus.
    Biochemistry, 49(37): 7975-7. [Abstract] [Full-text]
  47. Active surveillance culturing impacts methicillin-resistant Staphylococcus aureus acquisition in a pediatric intensive care unit.
    Pediatr Crit Care Med. [Abstract] [Full-text]
  48. Sustained Reduction in Methicillin-Resistant Staphylococcus aureus Wound Infections After Cardiothoracic Surgery.
    Arch Intern Med. [Abstract] [Full-text]
  49. Methicillin-resistant Staphylococcus aureus in diabetic foot infections.
    Drugs, 70(14): 1785-97. [Abstract] [Full-text]
  50. Vascular surgical antibiotic prophylaxis study (VSAPS).
    Vasc Endovascular Surg, 44(7): 521-8. [Abstract] [Full-text]
  51. Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance.
    Int J Infect Dis. [Abstract] [Full-text]
  52. Methicillin-resistant Staphylococcus aureus colonization in HIV-infected outpatients is common and detection is enhanced by groin culture.
    Epidemiol Infect. [Abstract] [Full-text]
  53. A simplified multiplex PCR assay for fast and easy discrimination of globally distributed staphylococcal cassette chromosome mec types in meticillin-resistant Staphylococcus aureus.
    J Med Microbiol, 59: 1135-9. [Abstract] [Full-text]
  54. Socioeconomic determinants of outpatient antibiotic use in Europe.
    Int J Public Health, 55(5): 469-78. [Abstract] [Full-text]
  55. Meticillin-resistant Staphylococcus aureus isolated from foot ulcers in diabetic patients in a Chinese care hospital: risk factors for infection and prevalence.
    J Med Microbiol, 59: 1219-24. [Abstract] [Full-text]
  56. Acute Klebsiella pneumoniae pneumonia alone and with concurrent infection: comparison of clinical and thin-section CT findings.
    Br J Radiol, 83(994): 854-60. [Abstract] [Full-text]
  57. Screening methods for meticillin-resistant Staphylococcus aureus.
    J Med Microbiol, 59: 1153-5. [Abstract] [Full-text]
  58. Preservation of viability and antibacterial activity of Lactobacillus spp. in calcium alginate beads.
    Eur J Pharm Sci. [Abstract] [Full-text]
  59. Determinants of Choice and Prescription Patterns in Empiric Antibiotic Therapy for HAP/VAP.
    Eur Respir J. [Abstract] [Full-text]
  60. In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.
    Diagn Microbiol Infect Dis, 68(2): 181-5. [Abstract] [Full-text]
  61. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
    Curr Opin Pharmacol, 10(5): 516-21. [Abstract] [Full-text]
  62. Comparative effectiveness of linezolid and vancomycin among a national cohort of patients infected with methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(10): 4394-400. [Abstract] [Full-text]
  63. Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(10): 4107-11. [Abstract] [Full-text]
  64. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
    Antimicrob Agents Chemother, 54(10): 4329-34. [Abstract] [Full-text]
  65. Origin and molecular evolution of the determinant of methicillin resistance in staphylococci.
    Antimicrob Agents Chemother, 54(10): 4352-9. [Abstract] [Full-text]
  66. Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort.
    J Infect, 61(4): 299-306. [Abstract] [Full-text]
  67. Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities.
    Bioorg Med Chem Lett, 20(20): 6116-20. [Abstract] [Full-text]
  68. Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care.
    J Antimicrob Chemother. [Abstract] [Full-text]
  69. A family of pyrazinone natural products from a conserved nonribosomal peptide synthetase in Staphylococcus aureus.
    Chem Biol, 17(9): 925-30. [Abstract] [Full-text]
  70. Methicillin-resistant Staphylococcus aureus: the superbug.
    Int J Infect Dis. [Abstract] [Full-text]
  71. Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment.
    Crit Care Med, 38(10): 1991-5. [Abstract] [Full-text]
  72. Comparison of the antimicrobial activity of Ulmo honey from Chile and Manuka honey against methicillin-resistant Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.
    BMC Complement Altern Med, 10: 47. [Abstract] [Full-text]
  73. Recombinant antimicrobial peptide hPAB-β expressed in Pichia pastoris, a potential agent active against methicillin-resistant Staphylococcus aureus.
    Appl Microbiol Biotechnol. [Abstract] [Full-text]
  74. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Alberta, Canada: population-based surveillance, 2005-2008.
    Epidemiol Infect. [Abstract] [Full-text]
  75. Modulation of the local neutrophil response by a novel hyaluronic acid-binding peptide reduces bacterial burden during staphylococcal wound infection.
    Infect Immun, 78(10): 4176-86. [Abstract] [Full-text]
  76. Pathogenic role of macrophages in intradermal infection of methicillin-resistant Staphylococcus aureus in thermally injured mice.
    Infect Immun, 78(10): 4311-9. [Abstract] [Full-text]
  77. Sequential introduction of single room isolation and hand hygiene campaign in the control of methicillin-resistant Staphylococcus aureus in intensive care unit.
    BMC Infect Dis, 10: 263. [Abstract] [Full-text]
  78. Glycopeptide vs. non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review.
    Surg Infect (Larchmt), 11(5): 455-62. [Abstract] [Full-text]
  79. Comparison of incidence of bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 2006-2007.
    Clin Infect Dis, 51(8): 925-8. [Abstract] [Full-text]
  80. Staphylococcal scalded skin syndrome in an extremely low-birth-weight neonate: molecular characterization and rapid detection by multiplex and real-time PCR of methicillin-resistant Staphylococcusaureus.
    Pediatr Int. [Abstract] [Full-text]
  81. Severe ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus and other pathogens: report of a case successfully managed by serial surveillance cultures of endotracheal aspirates.
    J Infect Chemother. [Abstract] [Full-text]
  82. Spa Diversity among MRSA and MSSA Strains of Staphylococcus aureus in North of Iran.
    Int J Microbiol, 2010. [Abstract] [Full-text]
  83. The nosocomial transmission rate of animal-associated ST398 meticillin-resistant Staphylococcus aureus.
    J R Soc Interface. [Abstract] [Full-text]
  84. The Dominant Methicillin-Resistant Staphylococcus aureus Clone from Hospitals in Cape Town has an Unusual Genotype: ST612.
    Clin Microbiol Infect. [Abstract] [Full-text]
  85. Genotypes, Antibiotic Resistance Profiles and Microarray-Based Characterization of Methicillin-Resistant Staphylococcus aureus Strains Isolated from Livestock and Veterinarians in Switzerland.
    Zoonoses Public Health. [Abstract] [Full-text]
  86. In vitro susceptibility patterns of methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus corneal isolates to antibiotics.
    Cornea, 29(10): 1131-5. [Abstract] [Full-text]
  87. Suprathel-acetic acid matrix versus acticoat and aquacel as an antiseptic dressing: an in vitro study.
    Ann Plast Surg, 65(4): 391-5. [Abstract] [Full-text]
  88. Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit.
    Crit Care, 14(4): R159. [Abstract] [Full-text]
  89. Linezolid versus Glycopeptide Antibiotics for the Treatment of Suspected Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia: A Meta-Analysis of Randomized Controlled Trials.
    Chest. [Abstract] [Full-text]
  90. MRSA screening in the vascular day-case population.
    Ann R Coll Surg Engl. [Abstract] [Full-text]
  91. Pitucamycin: structural merger of a phenoxazinone with an epoxyquinone antibiotic.
    J Nat Prod, 73(9): 1461-4. [Abstract] [Full-text]
  92. The value of multiple surveillance cultures for methicillin-resistant Staphylococcus aureus.
    Am J Infect Control, 38(8): 596-9. [Abstract] [Full-text]
  93. Role of nasal methicillin-resistant Staphylococcus aureus screening in the management of skin and soft tissue infections.
    Am J Infect Control, 38(8): 657-9. [Abstract] [Full-text]
  94. Health care-associated and community-associated methicillin-resistant Staphylococcus aureus infections: A comparison of definitions.
    Am J Infect Control, 38(8): 600-6. [Abstract] [Full-text]
  95. Molecular surveillance of Staphylococcus aureus colonization in a neonatal intensive care unit.
    Am J Infect Control, 38(8): 660-3. [Abstract] [Full-text]
  96. Hospital methicillin-resistant Staphylococcus aureus active surveillance practices in Los Angeles County: Implications of legislation-based infection control, 2008.
    Am J Infect Control, 38(8): 653-6. [Abstract] [Full-text]
  97. A stepwise approach to control an outbreak and ongoing transmission of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit.
    Am J Infect Control, 38(8): 607-11. [Abstract] [Full-text]
  98. Long-term persistence of MRSA in re-admitted patients.
    Infection, 38(5): 363-71. [Abstract] [Full-text]
  99. Identification of the active component that induces vancomycin resistance in MRSA.
    J Antibiot (Tokyo), 63(9): 533-8. [Abstract] [Full-text]
  100. Bilateral psoas abscesses caused by methicillin-resistant Staphylococcus aureus (MRSA) after posterolateral fusion of the lumbar spine.
    J Clin Neurosci, 17(11): 1465-7. [Abstract] [Full-text]
  101. Post-cesarean delivery infectious morbidity: Focus on preoperative antibiotics and methicillin-resistant Staphylococcus aureus.
    Am J Infect Control, 38(8): 612-6. [Abstract] [Full-text]
  102. Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia.
    J Hosp Med. [Abstract] [Full-text]
  103. Hospitalizations with healthcare-associated complicated skin and skin structure infections: Impact of inappropriate empiric therapy on outcomes.
    J Hosp Med. [Abstract] [Full-text]
  104. Preventing catheter-associated urinary tract infections: An executive summary of the Association for Professionals in Infection Control and Epidemiology, Inc, Elimination Guide.
    Am J Infect Control, 38(8): 644-6. [Abstract] [Full-text]
  105. Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland.
    Arch Dis Child, 95(10): 781-5. [Abstract] [Full-text]
  106. Complete genome sequence of Staphylococcus aureus strain JKD6159, a unique Australian clone of ST93-IV community methicillin-resistant Staphylococcus aureus.
    J Bacteriol, 192(20): 5556-7. [Abstract] [Full-text]
  107. Neonatal infections in England: the NeonIN surveillance network.
    Arch Dis Child Fetal Neonatal Ed. [Abstract] [Full-text]
  108. Novel Apramycin Resistance Gene apmA in Bovine and Porcine Methicillin-resistant Staphylococcus aureus ST398.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  109. Superhydrophilicity and antibacterial property of a Cu-dotted oxide coating surface.
    Ann Clin Microbiol Antimicrob, 9: 25. [Abstract] [Full-text]
  110. Complicated skin and soft tissue infection.
    J Antimicrob Chemother, 65: iii35-44. [Abstract] [Full-text]
  111. Increase of Ceftazidime- and Fluoroquinolone-Resistant Klebsiella pneumoniae and Imipenem-Resistant Acinetobacter spp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007.
    Yonsei Med J, 51(6): 901-911. [Abstract] [Full-text]
  112. Efficacy and safety of linezolid in immunocompromised children with cancer.
    Pediatr Int, 52(5): 694-8. [Abstract] [Full-text]
  113. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids.
    Biomaterials. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2012 MRSA Research Today. All Rights Reserved.



MRSA Research Today Archive:

Volume 1 (2004)
  Issue 1 (October)
  Issue 2 (November)
  Issue 3 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



MRSA Books

License To Kill

License To Kill